— Know what they know.
Not Investment Advice
Also trades as: WGSWW (NASDAQ) · $vol 0M

WGS NASDAQ

GeneDx Holdings Corp.
1W: -8.7% 1M: -27.0% 3M: -1.5% YTD: -52.6% 1Y: -51.3% 3Y: +1866.8% 5Y: -74.9%
$62.74
+1.48 (+2.42%)
 
Weekly Expected Move ±12.9%
$42 $49 $56 $63 $71
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 38 · $1.9B mcap · 29M float · 2.66% daily turnover · Short 65% of daily vol
Credit Risk of going bust: higher than 54% of companies Debt: 8.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.53 (down 99.2%), GeneDx Holdings Corp. would be worth roughly what it owes.
Total debt $167.4M against a stock market value of $1.87B.
Distance to default 4.74 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $54.1M (short-term plus half of long-term), stock volatility 72.9%; Altman Z'' -7.87. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Smart Money Score
Bullish 75
Insider+$93.1M
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.9B
52W Range32.21-170.87
Volume926,802
Avg Volume768,736
Beta1.97
Dividend—
Analyst Ratings
10 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOKatherine A. Stueland
Employees1,300
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2020-11-04
Websitegenedx.com
North Tower
Stamford, CT 06902
US
800 298 6470
About GeneDx Holdings Corp.

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

Recent Insider Trades

NameTypeSharesPriceDate
Fuchs Thomas M-Exempt 1,146 — 2026-09-17
Fuchs Thomas M-Exempt 1,146 — 2026-09-17
Stueland Katherine M-Exempt 18,750 — 2026-09-16
Stueland Katherine S-Sale 1,648 $94.26 2026-09-16
Stueland Katherine S-Sale 148 $95.41 2026-09-16

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms